Tci Wealth Advisors, Inc. Kura Oncology, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	BUY	$11.78 - $16.98 $3,746 - $5,399	318 New	318 $5,000
Q4 2021 Jan 24, 2022	SELL	$12.22 - $19.57 $1,955 - $3,131	-160 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$15.42 - $21.72 $2,467 - $3,475	160 New	160 $3,000
Q2 2021 Aug 02, 2021	SELL	$20.85 - $29.88 $1,334 - $1,912	-64 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$24.75 - $39.14 $1,584 - $2,504	64 New	64 $2,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.